Are you Dr. Thertulien?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 90 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
125 Queens Rd Ste 610
Charlotte, NC 28204Phone+1 980-302-6600Fax+1 980-302-6605
Summary
- Dr. Raymond Thertulien, MD is an oncologist in Charlotte, North Carolina. He is currently licensed to practice medicine in North Carolina, Michigan, and Connecticut. He is affiliated with Novant Health Presbyterian Medical Center, Mission Hospital McDowell, and AdventHealth Hendersonville.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1996 - 2001
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1994 - 1997
University of Rochester School of Medicine and DentistryClass of 1994
Certifications & Licensure
NC State Medical License 2007 - 2025
NY State Medical License 1996 - 2023
MI State Medical License 2008 - 2012
CT State Medical License 2005 - 2010
AR State Medical License 2001 - 2006- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches Start of enrollment: 2014 Nov 01
- Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer Start of enrollment: 2014 Sep 01
- Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers Start of enrollment: 2015 Dec 29
- Join now to see all
Publications & Presentations
PubMed
- 20 citationsThrombolytic therapy is effective in paroxysmal nocturnal hemoglobinuria: a series of nine patients and a review of the literature.David J. Araten, Rosario Notaro, Howard T. Thaler, Nancy A. Kernan, Farid Boulad
Haematologica. 2012-03-01 - 11 citationsSecond malignancies among Waldenstrom macroglobulinemia patients: small samples and sparse dataRohit P. Ojha, Raymond Thertulien
Annals of Oncology. 2012-02-01 - 54 citationsPhase 2 trial of Linifanib (ABT-869) in patients with advanced non-small cell lung cancer.Eng Huat Tan, Glenwood D. Goss, Ravi Salgia, Benjamin Besse, David R. Gandara
Journal of Thoracic Oncology. 2011-08-01
Press Mentions
New Oncologist to Practice in Asheville, MarionAugust 12th, 2017
Can Her Life Be Extended or Not? One NC Cancer Patient’s Wait for Medicaid ExpansionSeptember 8th, 2023
Professional Memberships
- Member
